#251 But I am not Depressed: Antidepressants for Irritable Bowel Syndrome
CLINICAL QUESTION
Do antidepressant medications improve irritable bowel syndrome (IBS) symptoms?
BOTTOM LINE
Both tricyclic antidepressants (TCAs) and selective serotonin reuptake inhibitors (SSRIs) may improve overall IBS symptoms. About 55% of patients treated with TCAs or SSRIs will benefit compared to ~35% with placebo. Only TCAs improve abdominal pain for ~60% of patients compared to ~30% with placebo. TCA studies reported more side effects (drowsiness and dry mouth) than SSRIs.
Reading Tools for Practice Article can earn you MainPro+ Credits
Join NowAlready a CFPCLearn Member? Log in
EVIDENCE
Focusing on the most recent systematic review, which included 18 randomized controlled trials (RCTs); 1127 adult patients; 42-100% female; IBS subtype usually not specified. Patient reported outcomes presented where available.1
- Tricyclic antidepressants (TCAs): 12 RCTs (787 patients) of amitriptyline, imipramine, desipramine, trimipramine, doxepin, and nortriptyline, versus placebo. Over 6-12 weeks:
- Global IBS symptom improvement: 57% TCA versus 36% placebo; number needed to treat (NNT)=5.
- Abdominal pain improvement: 59% TCA versus 28% placebo; NNT=4.
- Adverse Events (mostly drowsiness, dry mouth): 36% TCA versus 20% placebo; number needed to harm (NNH)=7.
- SSRIs: 7 RCTs (356 patients) of fluoxetine, paroxetine, and citalopram. Over 6-12 weeks:
- Global IBS symptom improvement: 55% SSRI versus 33% placebo; NNT=5.
- Abdominal pain improvement: 45% SSRI versus 26% placebo; not statistically different.
- Adverse events: 37% SSRI versus 27% placebo; not statistically different.
- Evidence limited by:
- Small sample sizes, short study duration, and likely publication bias.
- Adverse events not reported in all studies.
- Older systematic reviews show similar results.2,3
- Canadian guidelines recommend offering TCAs or SSRIs, irrespective of whether patients have depression or anxiety.4
- Up to 5 million adult Canadians may have symptoms compatible with IBS.5
- Indirectly, evidence for antidepressants in IBS appears stronger than antispasmodics,6 fiber,4 FODMAP diet,7 or probiotics.4
- TCAs may work better for IBS-diarrhea subtype, while SSRIs may work better for IBS-constipation subtype, but this has not been formally studied.4
- Patients suspected of having IBS should have celiac disease ruled-out.
Latest Tools for Practice
#378 Tony Romo-sozumab: Winning touchdown in osteoporosis or interception for the loss?
What is the efficacy and safety of romosozumab in postmenopausal women with osteoporosis?
#377 How to slow the flow IV: Combined oral contraceptives
In premenopausal heavy menstrual bleeding due to benign etiology, do combined oral contraceptives (COC) improve patient outcomes?
#376 Testosterone supplementation for cis-gender men: Let’s (andro-)pause for a moment (Update)
What are the benefits and harms of testosterone supplementation in healthy cis-gender men or those with age-related low testosterone?
